SynthesisFrontiers in pharmacology2022

Chemotherapy Combined With Immunotherapy as a First-Line Treatment Brings Benefits to Patients With Lung Squamous Cell Carcinoma but Different Risks of Adverse Reactions: A Systematic Review and Meta-Analysis.

Qian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.